Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Blue Chips Continue Rally, but Nasdaq 100 Lags

Thu. October 15, 2009; Posted: 05:56 PM
Stocks RSS
Oct 15, 2009 (AdviceTrade via COMTEX) -- ACOR | Quote | Chart | News | PowerRating -- Blue Chips Continue Rally, but Nasdaq 100 Lags By Harry Boxer, www.TheTechTrader.com an AdviceTrade.com publication

The indices managed to squeeze out a gain on the blue chips, but the Nasdaq 100 was down a very small fraction and the Philadelphia Semiconductor Index (SOXX) got hit for more than 1%, so it was a mixed close.

But the S&P 500 closed going away at the exact high for the day, spiking up at the close. The NDX did manage to rally late in the session and close near the session highs, but still trailed the SPX and that may have created a negative divergence.

The day started out with a gap down, but they immediately bounced and then went to lower lows but held support. They bounced around for a few hours, continuing to hold support. When that occurred they rallied to mid-afternoon, pulled back in the last hour, but in the last 10 minutes spiked back up again.

Net on the day the Dow was up 47.08 to 10,062.94, about 85 points off its low, the S&P 500 up 4.54 to 1096.56, 10 points off its low, and the Nasdaq 100 down 90 cents on the day to 1753.36, 11 points off its low. The Philadelphia Semiconductor Index closed at 329.78, down 4.73.

Advance-declines barely edged to the upside by 19 issues on New York, but were nearly 350 issues negative on Nasdaq. Up/down volume was slightly higher on New York on total volume of 1.3 billion. Nasdaq traded more than 2.1 billion and had about a 4 to 3 negative volume ratio.

TheTechTrader.com board was mostly narrowly mixed, but there were a few point plus movers.

Acordia Pharmaceuticals (ACOR) on FDA approval of their drug soared 7.91 to 24.65 on 13 million. The U.S. Oil Fund ETF (USO) was up 1.30 at 39.91, as oil broke through $77 a barrel.

Those were the only point-plus gainers on our board.

On the downside financials had a weak session, with Goldman Sachs (GS) down 3.65 at 188.63. The Direxion Financial Bull 3x Shares (FAS) lost 1.93 to 91.96.

Among the fractional gainers, biotechs generally had a positive session. Dendreon (DNDN) added 58 cents to 29.91, at one point over 30. Jazz Pharmaceuticals (JAZZ) jumped 87 cents to 8.66 on 3 ¼ million. Vanda Pharmaceuticals (VNDA) continued its snapback, up 37 cents to 11.88.

Interestingly enough the Direxion Financial Bear 3x Shares (FAZ) was up 35 cents today to 17.88.

Stepping back and reviewing the hourly chart patterns, continuing the consolidation of the last two sessions, the indices backed and filled most of the day, rallied in the afternoon, and broke out late in the session on the SPX, but the NDX failed to confirm.

Good trading!

Harry

For more of Harry Boxer, sign up for a Free 15-Day Trial to his Trading Diary. (https://www.thetechtrader.com/reg/bb)

thetechtrader.com
For full details on Acorda Therapeutics Inc (ACOR) click here. Acorda Therapeutics Inc (ACOR) has Short Term PowerRatings of 4. Details on Acorda Therapeutics Inc (ACOR) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ACOR]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.